Biotechnology

It’s worth keeping an eye on Vertex Pharma (VRTX) stock. Here’s why

April 13, 2021

Will restructuring, cost-cutting help Walgreens (WBA) beat COVID blues?

April 1, 2021

Here’s what you need to know before investing in Amgen (AMGN)

March 31, 2021

With a Phase 2 success, Entera Bio’s pipeline might be worth betting on

March 23, 2021

Transcript

Entera Bio Ltd. (ENTX) Q4 2020 Earnings Call Transcript

March 23, 2021

Transcript

Avid Bioservices, Inc. (CDMO) Q3 2021 Earnings Call Transcript

March 8, 2021

Moderna (MRNA) to increase vaccine supply capacity and accelerate pipeline investments

February 25, 2021

Transcript

Sage Therapeutics Inc. (SAGE) Q4 2020 Earnings Call Transcript

February 24, 2021

Transcript

Jazz Pharmaceuticals PLC (JAZZ) Q4 2020 Earnings Call Transcript

February 23, 2021

Solid pipeline makes ImmunoGen (IMGN) a good long-term investment

February 16, 2021

Transcript

ImmunoGen Inc. (IMGN) Q4 2020 Earnings Call Transcript

February 12, 2021

Transcript

Corcept Therapeutics Incorporated (CORT) Q4 2020 Earnings Call Transcript

February 8, 2021

Eylea recovery, COVID antibody cocktail make Regeneron an attractive bet

February 8, 2021

Transcript

Regeneron Pharmaceuticals, Inc. (REGN) Q4 2020 Earnings Call Transcript

February 5, 2021

Bristol Myers (BMY) stock gains after Q4 results beat Street view

February 4, 2021

Transcript

Biogen, Inc. (BIIB) Q4 2020 Earnings Call Transcript

February 3, 2021

Infographic: Key financials of Biogen (BIIB) Q4 2020 earnings report

February 3, 2021

Transcript

Vertex Pharmaceuticals Inc (VRTX) Q4 2020 Earnings Call Transcript

February 1, 2021

Novavax (NVAX) brings its share to the COVID-19 vaccine table; stock soars

January 29, 2021

Fate Therapeutics (FATE) looks headed for a turnaround post-COVID

January 26, 2021

Codexis (CDXS) may be moving closer to profitability, after beating slowdown

January 21, 2021